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A B S T R A C T
Bovine viral diarrhoea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) are contagious bovine viral agents.
The objectives of this study were to use quarterly bulk milk and ‘spot’ testing of unvaccinated youngstock
to establish the national prevalence of exposure to BVDV and/or BoHV-1 in Irish dairy herds. Seasonal-
ity of bulk milk ELISA results was also examined. From a geographically representative population of 305
dairy herds, 88% and 80% of herds yielded mean annual positive bulk milk readings for BVDV and BoHV-
1, respectively. Of these, 61% were vaccinated against BVDV and 12% against BoHV-1. A total of 2171 serum
samples from weanlings having a mean age of 291 days yielded 543 (25%) seropositive for BVDV, and
117 (5.4%) seropositive for BoHV-1. A significant seasonal trend in bulk milk antibody ELISA readings and
herd status was recorded for BVDV, with more herds categorised as positive in the latter half of the year.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Bovine viral diarrhoea (BVD), caused by BVD virus (BVDV), and
infectious bovine rhinotracheitis (IBR), caused by bovine herpes-
virus 1 (BoHV-1), are highly contagious viral diseases of cattle
(Moennig et al., 2005; Muylkens et al., 2007; Nandi et al., 2009).
Both exhibit a worldwide distribution (Lindberg et al., 2006; Thiry
et al., 2006) and are listed as notifiable diseases by the Office In-
ternational des Epizooitic1 (OIE). Although OIE-listed diseases,
compulsory national control programmes for BVDV and BoHV-1 do
not exist in many countries (Ackermann and Engels, 2006; Heffernan
et al., 2009).
Where regulation does exist, successful BVDV eradication has
been achieved through the use of ‘test and cull’ protocols involv-
ing removal of persistently infected (PI) individuals (Heffernan et al.,
2009; Lindberg et al., 2006; Moennig et al., 2005; Presi et al., 2011;
Ridpath, 2012; Ståhl and Alenius, 2012; Valle et al., 2005). In the
case of BoHV-1, vaccination with marker/DIVA (Differentiating In-
fected from VAccinated) vaccines (Mars et al., 2001; Nandi et al.,
2009; Nardelli et al., 2008; van Oirschot, 1999) constitutes the
primary method of control and eradication in high prevalence
regions. In January 2013, a mandatory national eradication pro-
gramme for BVD, coordinated by the Animal Health Ireland (AHI),
was introduced in the Republic of Ireland (Graham et al., 2013). As
yet, a co-ordinated approach to BoHV-1 control does not exist in
Ireland.
In order to determine the necessity for, and measure ongoing
success of an eradication programme, it is useful to conduct prev-
alence studies to obtain baseline data (Heffernan et al., 2009;
Lindberg et al., 2006; Lindberg and Alenius, 1999; Paisley et al., 2001).
National prevalence studies, however, are often prohibitively ex-
pensive (Thrushfield, 2005). The advent of bulk milk testing
overcomes this issue and reliable antibody detection bulk milk test
procedures have been developed for both BVDV and BoHV-1
(Beaudeau et al., 2001; Nylin et al., 2000). Bulkmilk analysis for BVDV
antibodies, however, does not readily distinguish between vacci-
nated and unvaccinated herds (Lindberg et al., 2006). This issue has
been overcome in the case of BoHV-1 with the advent of BoHV-1
gE-deleted DIVA vaccines. Due to legislative requirements,2 all
BoHV-1 vaccines administered in the Republic of Ireland since De-
cember 31, 2004 are DIVA vaccines (Simon, 2004).
Additionally, bulk milk BVD antibody readings may reflect his-
torical rather than current herd viral status (Brülisauer et al., 2010;
Lindberg and Alenius, 1999). To overcome this issue, it is useful to
test unvaccinated homeborn youngstock (weanlings) for antibod-
ies against BVDV, i.e. a ‘spot test’ (Houe, 1992, 1994; Mars and Van
Maanen, 2005). Positive antibody readings in this population, once
maternal antibodies have dissipated, can be indicative of current
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or recent viral circulation (Houe, 1992, 1994; Lindberg and Alenius,
1999), and as such provide a useful adjunct to bulk milk testing.
Although preliminary surveillance studies have indicated high
levels of both BVDV and BoHV-1 in the Irish national cattle popu-
lation (Cowley et al., 2011, 2012; O’Grady et al., 2008; O’Neill et al.,
2009), national prevalence data for BVD and BoHV-1 exposure among
a geographically representative sample of Irish dairy farms are not
available. In addition, evaluation of longitudinal BVD and BoHV-1
bulk milk data over a single lactation in a predominantly spring-
calving dairy system has not been reported previously. The primary
objective of this study, therefore, was to use bulk milk analysis and
spot testing of Irish dairy herds to generate national prevalence data
for both BVD and BoHV-1, while investigating the usefulness of this
diagnostic strategy in an Irish context.
2. Materials and methods
2.1. Sample population and survey
The study was licenced by the Irish Department of Health and
Children in 2009, meeting all legislative requirements for research
involving animals in the Republic of Ireland at the time of the study.
A detailed description of the sample population used in this study
is outlined in O’Doherty et al. (2013). Briefly, stratified proportion-
al sampling based on herd size and geographical location was used
to randomly select and invite 500 herds from the Irish Cattle Breed-
ing Federations (ICBF) database to partake in the study on a non-
incentivised basis. Over the 2009 lactation, four bulk milk samples
(23 March, 8 June, 31 August and 2 November) were submitted by
post in a standardised kit from each participating farm. Each study
farmwas visited between October 2009 and January 2010 to collect
blood samples by coccygeal venepuncture from 20% of the replace-
ment heifer group (weanlings for spot test) on each farm, with a
minimum of five weanling heifers sampled on each farm. All heifers
were homeborn and not vaccinated against BVDV. Where possi-
ble, only weanlings over 270 days of age were sampled, although
not achievable in all cases. Accurate weanling age based on calf reg-
istration data was downloaded from the ICBF database.
2.2. Sample analysis
Commercially available enzyme linked immunosorbent assay
(ELISA) kits were used to test bulk milk samples for the presence
antibodies against: (i) BVD p80 (NS3) protein, (Institut Pourquier,
France); (ii) Ultrapurified IBR lysate (Institut Pourquier, France) in
BoHV-1 unvaccinated herds; and (iii) IBRgE, (IDEXX laboratories, USA)
in BoHV-1 vaccinated herds. Weanling serum samples were also
tested for antibodies against BVD p80, ultrapurified IBR lysate, and
IBRgE with serum adapted positive cut-off values applied as out-
lined by kit manufacturers (Table 1). All analyses were completed
by commercial accredited laboratories; BVD p80 and IBR lysate by
National Milk Laboratories Ltd. (UK), and IBR gE by Enfer Diagnos-
tics Ltd. (Ireland).
2.3. Herd classification
Calving data from the ICBF were used to determine calving-
season of each herd (spring-calving and non-spring-calving, i.e.
spring-autumn [SA] and year-round [YR]) as described by O’Doherty
et al. (2013). Vaccination status (vaccinated [V] and unvaccinated
[UV]) was determined by questionnaire, with date of vaccination,
product used, and class of animal vaccinated (cows, yearling-
heifers, weanlings) recorded. In all cases, kit-manufacturer positive
cut-off values were applied to ELISA outputs in order to classify herds
as ‘positive’ or ‘negative’. Herds were classified as positive or neg-
ative at each of the four sampling time points (longitudinal data).
Additionally, a mean annual ELISA result for each herd (herd status
data) was calculated to provide an overall bulk milk classification
for each herd. Herds were also categorised on the basis of com-
bined BVDV and BoHV-1 bulk milk antibody status, i.e. negative for
both viral antibodies, positive for BoHV-1 and negative for BVD, neg-
ative for BoHV-1 and positive for BVD, and positive for both viral
antibodies.
Finally, herds were classified with regard to the presence of se-
ropositive unvaccinated weanlings. Two datasets were constructed
with weanlings either categorised ‘positive aged ≥180 days of age’
or ‘positive aged ≥270 days of age’ to both assess and minimise po-
tential interference from maternally derived antibodies (MDAs)
(Fulton et al., 2004). Herds having at least one weanling serologi-
cally positive for either BVDV or BoHV-1 were classified as having
‘evidence of recent viral circulation’ (RVC) (Houe, 1992; Handel et al.,
2011). Herds not recording a positive weanling or recording a pos-
itive weanling under either 180 or 270 days of age, depending on
the dataset, were classified as ‘not having evidence of recent viral
circulation’ (NRVC).
2.4. Data analysis
Descriptive analysis and graphical representations were com-
pleted in Excel (MS Office 2010). Normality of the data was assessed
visually using ladder of powers histograms, with normality of re-
siduals assessed using normal probability plots and kernel density
estimate plots constructed in Stata (Version 12). True prevalence
was calculated using the Rogan–Gladen estimator in the survey
toolbox version 1.04 (www.ausvet.com.au (Cameron, 1999)). Pear-
son’s chi-squared, Fisher’s exact, univariable andmultivariable logistic
regression, generalised estimating equations (GEE), multinomial
logistic regression, Wilcoxon rank sum, and Hosmer–Lemeshow test
of goodness of fit analyses were carried out using Stata (Version 12).
Seasonal trends in true prevalence for both diseases were tabu-
lated. In addition, box plots of %inhibition, %S/P, and S/N ratio for
BVDp80, IBR lysate, and IBR gE, respectively, at each sampling time
Table 1
ELISA kit performance data and positive cut-off values for BVD and BoHV-1assays used in this study.
Test BVD P80
Milk
IBR Lysate
Milk
IBR gE
Milk
BVD P80
Serum
IBR lysate
Serum
IBR gE
Serum
Sensitivity 95.0% 100% 72.0–88.4% 97.6% 98.7% 100%
Specificity 97.7% 99.6% 100% 97.3% 99.9% >99%
Positive cut-off
(Kit)
≥55
%Inhibitiona
≥25
%S/Pb
≤0.8
S/N ratioc
>60
%Inhibitiona
>55
% S/Pb
≤0.60
S/N ratioc
Within-herd prevalence ≥30%d Not available 10.0–15.0%e n/a n/a n/a
a %Inhibition = [1 − (OD 450 of analysed sample / mean OD 450 of negative control)] × 100.
b %S/P = (OD 450 of sample − OD 450 of negative control) / (mean OD 450 of positive control − OD 450 of negative control) × 100.
c S/N ratio = (sample mean − absorbance 650 nm)/negative control mean.
d Beaudeau et al., 2001.
e Wellenberg et al, 1998; Kramps et al., 1994.
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point were constructed. Two BVD datasets were examined by GEE
and logistic regression, i.e. all study herds regardless of BVD vac-
cination status, and BVD unvaccinated herds only.
Longitudinal data were used for the purposes of GEE analysis.
To examine seasonal effects on bulkmilk analysis, a univariable anal-
ysis of bulk milk results (constructed as both categorical [positive
vs. negative] and continuous [ELISA readings] variables) and sam-
pling time point was completed (Woodbine et al., 2009).
Examination of additional influences on bulk milk longitudinal
data (both categorical and continuous) by a number of indepen-
dent variables was also completed. Independent variables examined
included region (high density dairy vs. low density dairy), herd size
(31–65 cows vs. 66–99 cows vs. > 99 cows), calving season (spring-
calving vs. non-spring-calving), type of farming enterprise (dairy
livestock only vs. mixed livestock), vaccination status (V vs. UV), and
recent viral circulation (RVC ≥180 days or RVC ≥270 days vs.
NRVC ≥180 days or NRVC ≥270 days). A total of four datasets were
analysed by GEE to account for BVD vaccination status (V, UV) and
differing weanling age groups (≥180 and ≥270 days of age).
Logistic regression was used to examine associations between
recent viral circulation status (RVC ≥180 or ≥270 days vs. NRVC ≥180
or ≥270 days) and vaccination status (V vs. UV), the dependent vari-
ables, and region, calving-season, enterprise-type, herd-size, and
annual mean bulk milk herd status (independent variables). Four
datasets were constructed to account for BVD vaccination status (V,
UV) and positive-weanling age (≥180 or ≥270 days).
Multinomial logistic regression analysis was completed on com-
bined BVDV and BoHV-1 bulk milk status with region, herd-size,
enterprise-type, calving-season and recent viral circulation status
as independent variables.
For all GEE analyses, herd was included as a repeated measure
and an exchangeable correlation used. A binomial distribution was
assumed and a logit link function applied for categorical data; a
Gaussian distribution and identity link function were used for con-
tinuous data. All regression models were constructed by first
completing a univariable analysis. Those variables recording p values
of ≤0.15 in univariable analyses were included in multivariable
models. A manual backwards elimination with a forward step was
used to buildmodels with variables recording p values of ≤0.05main-
tained. Second level interactions deemed biologically significant were
also included. The overall fit of regressionmodels was assessed using
the Hosmer–Lemeshow good of fit test following ordinary logistic
regression (categorical variables). Normality of residuals was as-
sessed following logistic regression (categorical variables) and linear
regression (continuous variables).
To examine differences in bulk milk readings between RVC herds
and NRVC herds, a Wilcoxon rank sum analysis was completed for
each sampling time point. Herds were examined based on vacci-
nation status (V and UV) for both BVDV and BoHV-1, and a third
analysis was completed for BVDV where all herds regardless of vac-
cination status were included. Both viral circulation infection
classifications were examined, i.e. herds with positive weanlings
greater than 180 or 270 days of age.
3. Results
A total of 312 herds were recruited to the study (Fig. 1), yield-
ing a sufficient sample size to achieve a 95% confidence level and
precision of 5% for a national dairy herd population of approxi-
mately 18,000 herds with an expected national prevalence of 70%.
A complete set of four bulk milk samples was not achieved for four
farms and vaccination data were not returned by three farmers. Of
the herds recruited to the study, 305 herds were therefore suit-
able for final analysis. Weanling ages were unavailable for eleven
herds and these data were excluded from statistical analysis.
Study herds have previously been shown to geographically rep-
resent the Irish national dairy farm population (O’Doherty et al.,
2013). The distribution of study herds across region, herd size, calving
season, and type of enterprise is included in Table 2. Approximate-
ly 60% of study participants were vaccinated against BVDV using
inactivated vaccines, with 12.5% vaccinating against BoHV-1 using
DIVA vaccines. A total of 33 study farms administered vaccines for
both BVDV and BoHV-1.
3.1. Prevalence of bulk milk positive herds
The apparent prevalence (Ap) of bulkmilk antibody positive herds
for BVDV and BoHV-1 was approximately 88% (80% in unvacci-
nated herds) and 80% (78% in unvaccinated herds), respectively. True
prevalence (Tp) and 95% CI at each sampling time point and across
vaccination status is outlined in Table 3. Concurrent exposure to
BVDV and BoHV-1 was detected in 72% of herds, with only 10 herds
recording bulk milk seronegative status for BVDV and BoHA-1. Sea-
sonal trends in ELISA readings for each disease are included in Fig. 2.
3.2. Seasonal pattern of bulk milk results
Univariable GEE analysis highlighted significant seasonal differ-
ences in BVDV and BoHV-1 herd status examined as both categorical
and continuous variables (Supplementary Table S1).
Multivariable analysis of exposure to BVDV and BoHV-1 as con-
tinuous variables highlighted a general increase in ELISA readings
as the year progressed for both BVD and BoHV-1 (Table 4). When
examined as categorical variables, a significant seasonal effect was
only observed for BVD bulk milk herd status and a significant in-
teraction between enterprise type and sampling time point was
highlighted (Table 4). Herds with a mixed livestock enterprise, in
general, were more likely to record a BVD positive bulk milk result
in the latter half of the year. This association was apparent regard-
less of BVD vaccination status. Visual examination of normal
probability plots and kernel density plots of residuals did not high-
light evidence of non-normality. Goodness of fit analyses for
Table 2
Distribution of study herds across region, herd size, calving-season and enterprise-type.
Regiona
(density)
Counties represented Herd size (cows) Calving season Enterprisec
31–65 66–99 >99 Spring SA/YRb Dairy Mixed
Region 1
(Low)
32.5%
Carlow, Cavan, Clare, Donegal, Dublin, Galway, Kildare, Laois, Leitrim,
Longford, Louth, Mayo, Meath, Monaghan, Offaly, Roscommon, Sligo,
Westmeath, Wexford, Wicklow
n = 29
9.5%
n = 26
8.5%
n = 44
14.4%
n = 75
24.6%
n = 24
7.9%
n = 52
17%
n = 46
15.1%
Region 2
(High)
67.5%
Cork, Kerry, Kilkenny, Limerick, Tipperary, Waterford, Limerick n = 52
17.0%
n = 72
23.6%
n = 82
26.9%
n = 190
62.3%
n = 16
5.2%
n = 88
28.9%
n = 118
38.7%
a Regions were chosen to correspond with Irish dairy farm distribution (Sayers et al., 2013) and to represent a natural geographical spread.
b SA/YR represents Spring-Autumn and Year-Round calving seasons.
c Type of enterprise was not supplied by a single participant.
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categorical data using ordinary logistic regression yielded non-
significant values ranging from p = 0.286 to p = 0.878.
Examination of individual herd results highlighted 15 herdswhich
recorded elevated BVD readings in August and November sam-
plings (Table 5), four of which (herds 67, 263, 273, 275) may be
suggestive of introduction of BVD virus to the lactating herd. Herd
263 reported diarrhoea, fever, and milk drop across the lactating
herd over the month of July prior to submission of the August bulk
milk sample. An additional herd (herd 142) administered vaccine
in September which may account for the elevated reading in No-
vember. Remaining herds, although having progressed to positive
herd status in either August or November, did not record suffi-
ciently elevated readings to be regarded as biologically significant
given a positive cut-off of 55% inhibition.
3.3. Youngstock serological status
A total of 2171 serum samples from weanlings having a mean
age of 291 days (range 109 to 549) were analysed, with 543 testing
seropositive for BVDV and 117 testing seropositive for BoHV-1. The
Connaught
Ulster
Leinster
Munster
(a)
(b)
Region 1
Region 2
Fig. 1. (a) Location of study herds and, (b) representation of the density of animals on dairy farms in Ireland.
Table 3
True prevalence (Tp) and 95% confidence interval (CI) of exposure to BVDV and BoHV-1
in Irish dairy herds of varying vaccination status at each sampling time point.
Sample date BVD IBR
Tp 95% CI (%) Tp 95% CI (%)
All herds n = 305
March 90.5 86.4,94.7
June 90.5 86.4,94.7
August 96.2 92.8,99.6
November 94.4 90.8,98.1
Unvaccinated herds only n = 113 n = 269
March 81.5 73.3,89.8 80.2 75.8,84.7
June 83.4 75.4,91.4 79.6 75.1,84.1
August 94.9 89.0,100.0 77.3 72.6,82.0
November 93.0 86.6,99.3 79.6 75.1,84.1
gE herds* n = 36
March 100 n/a
June 100 n/a
August 100 n/a
November 100 n/a
* Describes herds vaccinatedwith a BoHV-1DIVA vaccine and tested using a gE ELISA.
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age profile and BVDV/BoHV-1 serological test status of study wean-
lings is included in Fig. 3. At least one seropositive weanling over
180 days of age was identified in 119/294 study herds in the case
of BVDV, and 24/294 in the case of BoHV-1. If an age limit of 270
days was applied, 96/294 herds recorded a single seropositive BVDV
weanling and 18/294 a BoHV-1 seropositive weanling (Fig. 4). A total
of 10 herds recorded weanlings ≥180 days old seropositive for both
BVDV and BoHV-1, and 8 herds having concurrently seropositive
weanlings if an age limit of ≥270 days was applied.
3.4. Associations between herd demographics and bulk milk status
Regional differences in both BVDV and BoHV-1 herd classifica-
tionwere highlighted bymultivariable GEE analysis (Table 4), though
this was not consistent across all models. Study herds in the most
dairy dense region of Ireland (Region-2) were almost twice as likely
to be categorised as BVDV antibody positive over those in Region-1
when all herds, regardless of vaccination status, were included in
the model. The reverse was highlighted for BoHV-1, where herds
in Region-1 (the least dairy dense part of Ireland) were found to
be almost twice as likely as those in Region-2 to be categorised as
positive. Herd size was significantly associated with BoHV-1 herd
status, with larger herds (>99 cows) approximately four times more
likely than smaller herds to be categorised positive. Finally, vacci-
nation was associated with positive herd status for both BVD
(OR = 4.29) and BoHV-1 (OR = 31.88), with vaccinating herds more
likely to be categorised positive.
3.5. Associations between recent viral circulation status, vaccination,
and herd demographics
All models examined highlighted a significant association
between BVDV bulk milk antibody status and BVDV RVC, herds
having evidence of recent BVDV circulation at least three timesmore
likely to be bulk milk positive than those herds recording no sero-
positive weanlings (Supplementary Table S2 and Table 6). No such
association was highlighted in the case of BoHV-1 bulk milk anti-
body positive herds. A tendency for larger herds to have RVC for
either BVDV or BoHV-1 was highlighted, with non-spring-calving
herds also more likely to contain BVDV seropositive weanlings
(Table 6).
Larger herds were more likely to vaccinate for both BVDV and
BoHV-1 in this study population. In addition, herds vaccinating for
BVDV were more likely to also vaccinate for BoHV-1 and vice versa
(Table 7). There were tendencies for herds that were BoHV-1 bulk
milk antibody positive to vaccinate for BVDV and for non-spring-
calving herds to vaccinate for BoHV-1.
3.6. Multinomial logistic regression analysis
Multinomial logistic regression highlighted that compared to
herds bulk milk antibody negative for both BVDV and BoHV-1, larger
herds were more likely to be antibody positive for BoHV-1 and neg-
ative for BVDV (OR = 3.70, 95% CI = 1.52, 9.04, P = 0.004) and antibody
positive for both BVDV and BoHV-1 (OR = 2.67, 95% CI = 1.23, 5.81,
P = 0.013). In addition, compared to antibody negative herds, those
operating mixed livestock enterprises tended to be over three times
more likely than dairy-only herds to present with exposure to one
(OR = 4.04, P = 0.071, BoHV-1; OR = 3.35, P = 0.10, BVDV) or both viral
pathogens (OR = 4.84, P = 0.024).
3.7. Wilcoxon rank sum analysis
A significant difference was highlighted between RVC and NRVC
herds in terms of BVDV bulkmilk %inhibition readings when all herds
were included in the analysis regardless of vaccination status, with
z values ranging from −2.718 to −3.864 (Supplementary Table S3).
A similar result was generated for BVDV unvaccinated herds alone,
with z values ranging from −3.901 to −4.617. No significant differ-
ence in %inhibition was highlighted between BVDV vaccinated RVC
vs. NRVC herds, however. An analysis of BoHV-1 yielded similar
results, with a significant difference in ELISA outputs highlighted
for unvaccinated herds (with the sole exception of theMarch sample),
but no significant difference in ELISA readings between vacci-
nated RVC and NRVC herds (Supplementary Table S3).
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Fig. 2. Box plots outlining seasonal trendsa in bulkmilk ELISA readings across positive
(Pos) and negative (Neg) (i) BVD, (ii) BoHV-1 unvaccinated, and (iii) BoHV-1 vaccinated
herds in 2009.
aMar: March; June: June; Aug: August; Nov: November.
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4. Discussion
The design of disease control strategies should be built upon local
knowledge (Greiser-Wilke et al., 2003; Lindberg et al., 2006). This
current study aimed to document levels of exposure to BVDV and
BoHV-1 in the Irish dairy cattle population. Inclusion of both viruses
allowed data on concurrent exposure to BVD and BoHV-1 to be
investigated for the first time in Ireland. Although the current study
has highlighted a high level of exposure to both BVDV and BoHV-1,
levels are comparable to those reported for other regions (Garoussi
et al., 2008; Guarino et al., 2008; Paton et al., 1998; Ståhl et al., 2002;
Thobokwe et al., 2004; VanWuijckhuise et al., 1998;Woodbine et al.,
2009).
It has been reported that the level of antibodies to BVDV in milk
is inversely related to the amount of milk produced (Niskanen et al.,
1989). As the majority of herds included in the present study were
spring-calving with peak lactation occurring approximately 9 weeks
post-calving (Quinn et al., 2005), milk yield will reduce in the latter
half of the year. An increase in bulk milk antibody readings might
therefore be expected (Rikula et al., 2005), and indeed such a trend
Table 4
Multivariable GEE analysis of BVDV and BoHV-1 herd classification.
Dependent variable
Categorical
Independent variable Odds ratio Confidence interval (95%) p value Model
(p value)
BVD status
POSITIVE vs. NEGATIVE
(All herds included regardless of
vaccination status)
Region 2 vs. Region 1 2.02 1.09,3.84 0.027 Region
BVD vaccination
Sampling time point
Enterprise
Sampling time point*enterprise
(P < 0.001)
Vaccinated vs. Unvaccinated 4.29 1.09,8.06 <0.001
Mixed August vs. Mixed March 3.19 1.54,6.58 0.002
Mixed November vs. Mixed March 2.04 1.08,3.83 0.027
Mixed August vs. Mixed June 1.96 0.96,4.03 0.064*
BVD classification
POSITIVE vs. NEGATIVE
(UV herds only)
Mixed August vs. Mixed March 3.46 1.45,8.25 0.005 Sampling time point
(P < 0.001)Mixed November vs. Mixed March 2.38 1.07,5.29 0.032
IBR classification
POSITIVE vs. NEGATIVE
(All herds included)
Region 1 vs. region 2 1.77 0.98,3.18 0.056* Region
IBR vaccination
Herd size
(P < 0.001)
Vaccinated vs. Unvaccinated 31.88 0.92,1102.57 0.057*
>99cows vs. 31–65 cows 3.66 1.82,7.37 <0.001
>99cows vs. 66–99cows 4.15 2.11,8.19 <0.001
Continuous Coa CI p value Model
BVD ELISA readings Region 2 vs. Region 1 4.58 0.44,8.72 0.030 Region
BVD vaccination
Enterprise
Sampling time point
Enterprise*sampling time point
P < 0.001
Vaccinated vs. Unvaccinated 10.72 6.76,16.67 <0.001
August vs. March 4.53 2.66,6.39 <0.001
November vs. March 2.73 0.86,4.59 0.004
Mixed June vs. Mixed March 4.26 1.71,6.81 0.001
Mixed August vs. Mixed March 3.04 0.49,5.59 0.019
Mixed November vs. Mixed March 4.30 1.75,6.84 0.001
BoHV-1 ELISA readings
(excluding vaccinated herds i.e. those
tested using gE)
June vs. March 22.29 14.31,30.29 <0.001 Sampling time point
Herd size
P < 0.001
August vs. March 14.29 6.29,22.27 <0.001
November vs. March 47.82 39.84,55.81 <0.001
August vs. June −8.01 −16.00,−0.03 0.049
November vs. June 25.52 17.54,33.52 <0.001
November vs. August 33.54 25.55,41.53 <0.001
>99cows vs. 31–65 cows 68.33 40.82,95.83 <0.001
>99cows vs. 66–99cows 52.08 26.57,77.61 <0.001
a Co = Coefficient, i.e. the expected difference across the population.
* Denotes an interaction between two independent variables.
Table 5
Herds recording a change (negative to positive) in BVD bulk milk antibody status in August and November.
Herd identification Calving season Enterprise BVD vaccination status
(Date of vaccination)
Weanling status
180
March June August November
% inhibition
39 Spring Mixed UV Negative 27.93 43.45 58.37 60.42
54 Spring Dairy UV Positive 43.65 25.32 54.69 60.96
67 Spring Mixed UV Positive 19.59 49.72 72.74 62.59
92 Autumn Mixed UV Negative 51.5 38.11 71.62 19.45
139 Spring Dairy V
(April)
Negative 24.47 46.07 39.9 60.98
142 Spring Mixed V
(September)
Positive 51.26 48.52 61.65 84.84
152 Spring Mixed UV Negative 32.06 42.67 60.38 60.98
155 Autumn Mixed UV Negative 35.48 47.11 58.6 48.28
172 Spring Dairy V
(March)
Negative 39.58 43.92 46.71 57.75
184 Spring Mixed V
January
Positive 35.68 43.3 58.11 30.01
263 Spring Dairy UV Positive 51.35 54.17 81.58 83.54
273 Spring Mixed UV Positive 20.5 36.05 76.7 85.83
275 Spring Dairy V
(March)
Positive 54.24 35.95 71.09 74.98
278 Autumn Dairy V
(January)
Positive 52.76 31.74 55.1 53.43
291 Spring Dairy UV Negative 32.71 44.31 51.79 67.75
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was highlighted in the current study, particularly in the case of BVDV.
The increase, however, was not large, and in the majority of cases
could not be considered biologically significant. Woodbine et al.
(2009) reported similar results for BoHV-1 in England where a small
but significant seasonal association was detected. It has been re-
ported, however, that the total amount of secreted daily IgG is higher
during peakmilk production than later in lactation whichmay coun-
teract any dilution effect of increased milk production, thereby
contributing to the lack of major seasonal trends (Guidry et al., 1980;
Nylin et al., 2000).
It should be noted, however, that in the case of four farms, more
dramatic increases in BVD bulkmilk readingswere recorded between
the June and August sampling. Housing is more often associatedwith
spread of viral disease than is outdoor grazing (Ampe et al., 2012).
An increased risk of BVDV infection over the summer months was
unexpected, therefore, as Ireland is predominantly a pasture-
based livestock system (Shalloo et al., 2004), the vast majority of
cattle outdoors during the summer period. Outdoor grazing may,
however, present a greater opportunity for trans-boundary trans-
mission of BVDV between neighbouring farms. In addition, livestock
movements have been associated with increased risk of disease
spread (Gates et al., 2013), and as many landholdings in Ireland are
highly fragmented (O’Donnell et al., 2008), livestockmovements over
the summer months will increase.
With regard to application of a suitable disease monitoring strat-
egies in regions of high bulk milk seroprevalence for BVDV and
BoHV-1, testing of more than a single annual sample in bulk milk
seropositive herds would appear excessive in the short to medium
term. More frequent bulk milk surveillance would, however, be of
benefit in BVDV antibody negative herds, and possibly those herds
in the lowest positive quartile (Fig. 4; 55–78% inhibition), especial-
ly over the summer months, to allow rapid intervention in cases
of viral introduction.
There is value in documenting concurrent exposure to both BVDV
and BoHV-1, with studies such as that undertaken by Risalde et al.
(2013) outlining an increased severity in BoHV-1-associated tissue
lesions in the presence of sub-clinical BVDV infection. The present
study has highlighted, however, that although generation of con-
current disease status data is useful, application of a single
surveillance strategy for both is not appropriate. The results pre-
sented here highlighted an expected association between BVD bulk
milk antibody status and youngstock seropositivity based on previous
Fig. 3. Age and serological profile of study weanlings.
0 10 20 30 40 50 60
Positive weanlings - age unknown 
Multiple positive weanlings mixture of 180-270
and >270 days old 
Multiple positive weanlings all >270 days old 
Multiple positive weanlings all 180-270 days old 
Single positive weanling >270days old 
Single positive weanling 180-270 days old 
Positive weanlings <180 days 
Number of herds 
BoHV-1 
BVD 
Fig. 4. Number of herds containing varying ages and levels of seropositive youngstock.
Table 6
Logistic regression analysis of BVD and IBR recent infection status (180 days and 270 days).
Dependent variable
Independent variable
Odds ratio Confidence interval (95%) p value Model (p value) Model goodness of fit
(p value)
BVD recent infection 180a
66–99cows vs. 31–65 cows 1.80 0.93,3.47 0.079d Herd size
Calving season
Annual BVD herd status
(p = 0.0002)
p = 0.606
>99cows vs. 31–65cows 1.88 1.01,3.49 0.046
SA/YR vs. Spring 2.44 1.19,5.04 0.015
BVD positive vs. BVD negativec 4.86 1.79,13.15 0.002
BVD recent infection 270b
Region 2 vs. region 1 0.56 0.32,0.98 0.041 Region
Calving season
Annual BVD herd status
(p = 0.0001)
p = 0.970
SA/YR vs. Spring 2.39 1.15,4.96 0.019
BVD positive vs. BVD negativec 5.06 1.68,15.31 0.004
BoHV-1 recent circulation 180a
66–99cows vs. 31–65 cows 7.11 0.86,58.57 0.068d Herd size
(p = 0.005)
p = 0.615
>99cows vs. 31–65cows 8.35 1.07,65.04 0.043
BoHV-1 recent circulation 270b
Region 2 vs. region 1 0.40 0.15,1.06 0.066d Region
Herd size
(p = 0.034)
p = 0.202
>99cows vs. 31–65 cows 7.52 0.91,62.03 0.061d
>99cows vs. 66–99cows 5.79 0.72,46.85 0.100d
a Recent infection herd classification based on the presence of at least one seropositive weanling over 180 days of age.
b Recent infection herd classification based on the presence of at least one seropositive weanling over 270 days of age.
c BVDV annual mean herd status.
d Included for the purposes of highlighting a trend.
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investigations of spot testing (Houe et al., 2006). The use of BVD
spot test samples as a convenience sample for detecting the pres-
ence of BoHV-1 carriers in a herd, however, is not useful, with no
association between BoHV-1 seropositive weanlings and BoHV-1
bulk milk antibody status having been highlighted. The preva-
lence of BoHV-1 seropositive youngstock in both dairy and beef herds
tends to be low (Guarino et al., 2008; Romero-Salas et al., 2013;
Waldner and Kennedy, 2008), thereby reducing the usefulness of
this management group as herd sentinels. For the dairy herd there-
fore, wheremarker vaccines are used, bulkmilk antibody status alone
acts as a sufficient surveillance tool.
Given the similar methods of transmission of BVDV and BoHV-
1, the occurrence of regional differences in a small country such as
Ireland (agricultural land base is five million hectares approximate-
ly), having a large cattle population of approximately six million
bovines (CSO, 2007) and poor farm-level biosecurity (Sayers et al.,
2013), is noteworthy. Historically, BoHV-1 infections were verymuch
associated with respiratory disease in beef units as opposed to dairy
enterprises. Region-1, although the least cattle dense region of Ireland
with regard to dairy livestock, has a much higher proportion of beef
cattle, and farmers in this region are less likely to implement quar-
antine for purchased stock (Sayers et al., 2013). Both factors may
contribute to the higher probability of being BoHV-1 bulk milk pos-
itive in this region. A similar conclusion has been suggested by Dias
et al. (2013) where a predominantly dairying region of Brazil had
the lowest apparent prevalence of BoHV-1 than other regions ex-
amined. This differs from BVDV, where it is accepted that the
prevalence of BVDV is influenced by the regional cattle density
(Almeida et al., 2013; Garoussi et al., 2008; Handel et al., 2011; Houe
et al., 1995), and increased prevalence of BVDV is associated with
higher cattle densities, supporting the findings of this current study.
Regional effects were also noted in RVC herds in models includ-
ing youngstock of ≥270 days of age, with Region-2 less likely to have
a seropositive weanling than Region-1. Although logical for BoHV-1
based on bulk milk findings, the increased likelihood of Region-1
herds having RVC for BVDV seems counterintuitive, and Region-2
having higher BVD bulk milk antibody readings. As foetuses of se-
ropositive dams are rarely infected with BVDV, however (Brownlie
et al., 1998), higher bulk readings should indicate greater foetal pro-
tection in these herds, leading to fewer PIs born and less youngstock
exposed to BVDV. These findings are supported by a recent exam-
ination of the herd-level risk factors associated with the presence
of BVDV on Irish farms, with herds in Munster (Region-2) being sig-
nificantly less likely to produce one or more virus positive calves
than Connaught (Region-1) (Graham et al., 2013). The model which
included youngstock ≥180 days old did not yield a regional effect
and may reflect interference from BVDV MDAs which have a rela-
tively long half-life (Fulton et al., 2004).
In agreement with a number of other national and internation-
al studies (Boelaert et al., 2005; Cowley et al., 2011; Raaperi et al.,
2010; Solis-Calderon et al., 2003; Van Wuijckhuise et al., 1998;
Woodbine et al., 2009), a significant association between BoHV-1
infection/exposure and herd size was documented in this study,
though not all countries report such a finding (Billinis et al., 2005).
Larger herds also recorded higher ELISA readings in the current study.
This may be due to increased within-herd prevalence in these herds
as Raaperi et al. (2010) reported higher numbers of seropositive
animals in larger herds. Additionally, larger herds have more sus-
ceptible animals available to maintain infection and herd size is a
cluster variable for several biosecurity risks such as increased pur-
chase of animals and increased visitors (veterinary practitioners,
technicians, contract workers), all of which will increase the risk
of disease introduction and maintenance (Boelaert et al., 2005; van
Schaik et al., 1998). It is interesting to note that Sayers et al. (2013)
reported that larger herds in Ireland are more likely to join a herd
health scheme, which may reflect an awareness of the increased
disease risk on these farms. Additionally, larger herds in the current
study were also more likely to vaccinate for BVDV and BoHV-1, again
highlighting an awareness of the increased disease risk in these
herds.
The use of spot testing of youngstock is a well-establishedmethod
of documenting recent BVDV circulation in a herd (Houe et al., 2006)
to overcome the drawbacks of bulk milk analysis. To increase the
usefulness of bulk milk analysis alone in highlighting recent BVDV
circulation, Thobokwe et al. (2004) suggested a revised BVD ELISA
positive cut-off of 80% inhibition using the Pourquier ELISA, a cut-
off applied in a subsequent economic analysis (Heuer et al., 2007).
In order to examine the applicability of such a strategy in another
jurisdiction, aWilcoxon rank sum analysis was applied in the current
study to highlight differences in bulk milk analysis between herds
recording positive and negative spot tests. While the findings in part
aligned with those of Thobokwe et al. (2004), in that use of an el-
evated positive cut-off of 80% would be applicable to BVDV
unvaccinated herds at certain times of the year, its use for vacci-
nated herds in Ireland is not appropriate. Interpretation of spot
testing was stricter in this current study, however, which may
account for the difference between both studies.
5. Conclusion
Prevalence studies have an important role to play in highlight-
ing the necessity, or otherwise, for disease control and eradication
schemes. This study highlighted high levels of exposure to BVDV
and BoHV-1 in Irish dairy herds and also the lack of dramatic sea-
sonal differences in bulk milk ELISA results. In the short to medium
term, analysis of a single annual bulk milk sample would appear a
Table 7
Logistic regression analysis of BVD and IBR vaccination status.
Dependent variable
Independent variable
Odds ratio Confidence interval (95%) p value Model
(p value)
Model goodness of fit
(p value)
BVDV vaccination
66–99cows vs. 31–65 cows 2.08 1.11,3.89 0.023 Herd size
Annual BVD herd status
Annual IBR herds status
IBR vaccination
(p < 0.0001)
p = 0.299
>99cows vs. 31–65cows 2.61 1.40,4.88 0.003
BVD positive vs. BVD negativea 4.12 1.87,9.07 <0.001
BoHV-1 positive vs. IBR negativeb 1.79 0.96,3.32 0.065c
BoHV-1 vaccinated vs. unvaccinated 2.91 1.06,8.00 0.039
BoHV-1 vaccination
66–99cows vs. 31–65 cows 7.74 0.96,62.55 0.055c Herd size
Calving season
BVD vaccination
(p < 0.0001)
p = 0.494
>99cows vs. 31–65cows 15.11 1.98,115.36 0.009
SA/YR vs. Spring 2.40 0.94,6.12 0.067c
BVD vaccinated vs. unvaccinated 3.63 1.32,9.93 0.012
a BVD annual mean herd status.
b BoHV-1 annual mean herd status.
c Included for the purposes of highlighting a trend.
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suitable surveillance strategy for both BVDV and BoHV-1 in Ireland,
with spot testing required to highlight recent viral circulation in
BVDV vaccinated herds.
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